Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 4,121–4,140 of 17,299 recalls

FDA Recall Terminated Historical recordClass II

Triple Antibiotic Ointment, Bacitracin zinc, Neomycin sulfate, Polymixin B sulfate, First Aid Antibiotic, Triple Antibiotic Ointment, 144 packets per box, Net wt. per packet 0.5 g, Honeywell Safety Products, NDC 0498-0750-36.

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
CGMP Deviations: products were stored outside the drug label specifications.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lorazepam Injection, USP, 4mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# NDC# 0641-6045-25, Vial NDC# 0641-6045-01

by Hikma Pharmaceuticals USA Inc.

Reason
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01

by Hikma Pharmaceuticals USA Inc.

Reason
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6001-25, Vial NDC# 0641-6001-01

by Hikma Pharmaceuticals USA Inc.

Reason
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6044-25, Vial NDC# 0641-6044-01

by Hikma Pharmaceuticals USA Inc.

Reason
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc,m USA, Mahwah, NJ 07430, NDC 68462-841-13.

by Glenmark Pharmaceuticals Inc., USA

Reason
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430, NDC 68462-842-13.

by Glenmark Pharmaceuticals Inc., USA

Reason
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

NATURE'S SUNSHINE PRODUCTS

Product
Aivia Whey Protein+ Power Herbs Vanilla Bean, NET WT. 1.33 L…
Reason
Label declares Whey but does not declare Milk.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

NATURE'S SUNSHINE PRODUCTS

Product
Aivia Whey Protein+ Power Herbs Chocolate, NET WT 1.35 LBS (…
Reason
Label declares Whey but does not declare Milk.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

BrandStorm Inc

Product
Natierra Nature & Earth Organic Blueberries Ingredients: Org…
Reason
Elevated levels of lead detected as a result of testing conducted by Maryland Department of Health.
Published
August 17, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.

by Ultra Supplement LLC

Reason
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
Published
August 10, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285

by Distributor RFR, LLC.

Reason
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
Published
August 10, 2022
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Tacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDC 68462-534-35, b) 60 g tube, NDC 68462-534-65, c) 100 g tube, NDC 68462-534-94, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India.

by Glenmark Pharmaceuticals Inc., USA

Reason
Defective Container: Tube split from side seam
Published
August 10, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30.

by Teva Pharmaceuticals USA Inc

Reason
Failed Dissolution Specifications: below specification limits for dissolution.
Published
August 10, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.

by Teva Pharmaceuticals USA Inc

Reason
Failed Dissolution Specifications: below specification limits for dissolution.
Published
August 10, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Shopaax.com

Product
Kingdom Honey Royal Honey VIP The Ultimate Power Source; 12…
Reason
Undeclared Sildenafil
Published
August 10, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

by Pfizer Inc.

Reason
Presence of particulate matter: particulate identified as a beetle.
Published
August 3, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
Failed Dissolution Specifications
Published
August 3, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
Failed dissolution specifications.
Published
August 3, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV

by MYLAN PHARMACEUTICALS INC

Reason
Labeling: Missing label: Label missing from some prefilled pens.
Published
August 3, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.